Bortezomib in the Treatment of Multiple Myeloma edited by Irene M. Ghobrial, Paul G. Richardson, Kenneth C. Anderson.
Multiple Myeloma (MM) is the second most common type of blood cancer, resulting from an overproduction of cancerous infection-fighting white blood cells, known as plasma cells. Plasma cells are a crucial part of the immune system responsible for the production of antibodies. Bortezomib is a promisin...
Full description
Saved in: